İsveç - İsveççe - Läkemedelsverket (Medical Products Agency)

stada arzneimittel ag - lakosamid - filmdragerad tablett - 200 mg - lakosamid 200 mg aktiv substans

İsveç - İsveççe - Läkemedelsverket (Medical Products Agency)

zentiva k.s. - lakosamid - filmdragerad tablett - 200 mg - lakosamid 200 mg aktiv substans

İsveç - İsveççe - Läkemedelsverket (Medical Products Agency)

zentiva k.s. - lakosamid - filmdragerad tablett - 100 mg - lakosamid 100 mg aktiv substans

İsveç - İsveççe - Läkemedelsverket (Medical Products Agency)

zentiva k.s. - lakosamid - filmdragerad tablett - 50 mg - lakosamid 50 mg aktiv substans

İsveç - İsveççe - Läkemedelsverket (Medical Products Agency)

zentiva k.s. - lakosamid - filmdragerad tablett - 150 mg - lakosamid 150 mg aktiv substans

Avrupa Birliği - İsveççe - EMA (European Medicines Agency)

ucb pharma sa - lakosamid - epilepsi - antiepileptika, - vimpat indikeras som monoterapi och kompletterande terapi vid behandling av partiella anfall med eller utan sekundär generalisering hos vuxna, ungdomar och barn från 4 år med epilepsi.

Avrupa Birliği - İsveççe - EMA (European Medicines Agency)

ucb pharma s.a. - lakosamid - epilepsier, delvis - antiepileptika, - lacosamide ucb är indicerat som monoterapi och som tilläggsbehandling vid behandling av partiella anfall med eller utan sekundär generalisering hos vuxna, ungdomar och barn från 4 års ålder med epilepsi.

Avrupa Birliği - İsveççe - EMA (European Medicines Agency)

accord healthcare s.l.u. - lakosamid - epilepsi - antiepileptika, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Avrupa Birliği - İsveççe - EMA (European Medicines Agency)

extrovis eu ltd. - lakosamid - epilepsi - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

İsveç - İsveççe - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - lakosamid - filmdragerad tablett - 150 mg - lakosamid 150 mg aktiv substans